Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Major investors Nvidia and Novo Holdings A/S have fully exited their positions in Recursion Pharmaceuticals (NasdaqGS:RXRX), signaling a shift in institutional backing. Recursion has acquired full ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

FDA truncates drug approval process; Makary pushes for more OTC drugs; Inside the rocky ride for Recursion Pharmaceuticals.

Dead languages aren't as unimportant as they seem, because learning Latin, Sanskrit and Ancient Greek will make coding easier ...

By understanding automation as a continuum — from water wheels to factory assembly lines to modern LLMs — students develop frameworks for thinking about any tool that might emerge, rather than just ...

That hasn’t stopped Ovid Therapeutics from pressing ahead with first-in-class therapies for challenging brain disorders. Since its 2014 launch, Ovid has maintained a particularly staunch commitment to ...

The art and digital culture festival reminded us that networked, relational structures have a robust tradition outside big ...

The past is fast losing its reliability as a guide to the future in an age of exponentially evolving AI. As error rates drop ...

New releases from OpenAI and Anthropic sparked an existential crisis among coders, but many engineers say they stopped coding ...

A marriage of formal methods and LLMs seeks to harness the strengths of both.

For years, people have obsessed over the 'Doomsday Clock' as a symbolic warning of nuclear apocalypse. But the real danger we should all be frightened of is a risk of our own making - AI.